Showing Results for: “diabetes”

Losing my daughter, Diani, to type 1 diabetes changed the course of my life forever. Diani was diagnosed at 18, just as she stepped into adulthood, full of joy, ambition, and dreams. Suddenly, her world was filled with restrictions, calculations, and constant reminders that her health now rested in daily insulin injections, balanced meals, and careful monitoring. As bright and strong as she was, this new reality was hard for her to accept. Managing diabetes became not just a medical challenge, but an emotional and psychological one—a daily reminder of what had changed. Over the years, Diani

I remember having a fun night with my family at the park. We bought McDonald's and ate there. It was a great night. I ate so much food and played so hard. But when we got home, I fell ill. After that night, I didn't get better. It was at the age of 8 that I found myself within the throes of diabetic ketoacidosis. For a week, my symptoms crescendoed from frequent thirst and urination to abdominal cramps and not being able to keep anything down. By April 29 of 2010, my butt was parked in the ICU unit at Loma Linda Children's Hospital—that was the day my life changed forever. But it's also the

The American Diabetes Association ® (ADA) and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity, and metabolic dysfunction and how nutrition formulas can support those needs and overall health. More than 2 in 5 adults in the U.S. are living with obesity and approximately 1 in 10 Americans are living with diabetes, most of which is type 2 diabetes. 1,2 They may have nutritional deficiencies that go undiagnosed, which can have implications on their overall health. Adequate nutrition and nutrition support have shown to

Today, findings from two phase 2 clinical trials showcase new data for an investigational, once-weekly injectable glucose-dependent insulinotropic polypeptide (GIP)/ glucagon-like peptide 1 (GLP-1) /glucagon (GCG) receptor agonist, retatrutide. One study was conducted in people with obesity and included a substudy in patients who also had non-alcoholic fatty liver disease (NAFLD) and the second study included patients with type 2 diabetes (T2D). These studies were presented during the symposium entitled “Retatrutide (LY3437943), a Novel GIP/GLP 1/Glucagon Receptor Triagonist—Obesity, NAFLD

Diabetes isn’t going anywhere, so let’s work together and do our part. What exactly does that mean? During the month of November, the American Diabetes Association® (ADA) will educate everyone on diabetes and its complications by showcasing simple steps that can be taken to recognize, reduce risks, and ease the burden of diabetes. According to the Centers for Disease Control and Prevention, 40% of people who passed away from Covid-19 were living with diabetes. Now it is time to act and take necessary steps, collectively, to turn our post-COVID reality into a proclamation for better health and

For more than seven decades, ADA Camp has equipped children living with diabetes with lifelong skills to manage diabetes while their families can be confident that they are in a safe and fun-filled environment Registration is open for the 2026 American Diabetes Association ® (ADA) Camp season, offering children and families a medically safe and empowering environment to not only learn, but connect with peers and thrive while living with diabetes. The ADA hosts over 40 camps in 28 states across the country, featuring weekend or week-long day or overnight sessions that are designed for children

“The American Diabetes Association ® (ADA) applauds the long-awaited passage of Medicaid expansion in North Carolina. With more than 1 million people in North Carolina living with diagnosed diabetes, ADA believes this is a transformative step towards improving health access and health outcomes. An individual’s ability to manage diabetes is directly tied to his or her ability to access affordable and adequate health insurance coverage. States that have expanded Medicaid have seen a vast improvement in self-reported access to care and diabetes management, providing enrollees with vital access to

In his State of the Union address tonight President Biden discussed efforts to lower health care costs, make prescription drugs more affordable, and improve access to health care. In response, Lisa Murdock, chief advocacy officer at the American Diabetes Association® (ADA) issued the following statement: “The American Diabetes Association welcomes efforts to reduce health care costs for people living with diabetes. People with diagnosed diabetes now account for one of every four health care dollars spent in the U.S. The ADA has long led the fight to make diabetes treatment more affordable, and